REFERENCES
P. G. Welling and F. L. S. Tse, ed. Drugs and the Pharmaceutical Sciences, 33, Pharmacokinetics Regulatory, Industrial, Academic Perspectives. Marcel Dekker, Inc., New York, 1988, p 231–238.
C. C. Peck, W. H. Barr, L. Z. Benet, J. Collins, R. E. Desjardins, D. E. Furst, J. G. Harter, G. Levy, T. Ludden, J. H. Rodman, L. Sanathanan, J. J. Schentag, V. P. Shah, L. B. Sheiner, J. P. Skelly, D. R. Stanski, R. J. Temple, C. T. Viswanathan, J. Weissinger, and A. Yacobi, Clin. Pharmacol. Ther., 41, 465–473 (1992).
21 CFR 361.1 Revised April 1 (1987).
R. Temple, J. Nucl. Med., 26, 815–816 (1985).
W. R. Hendee, Radioactive Isotopes in Biological Research. John Wiley and Sons, New York, 1973, p. 289.
W. R. Hendee, Radioactive Isotopes in Biological Research. John Wiley and Sons, New York, 1973, p. 300.
P. G. Welling and F. L. S. Tse, ed. Drugs and Pharmaceutical Sciences, 33, Pharmacokinetics Regulatory, Industrial, Academic Perspectives. Marcel Dekker Inc., New York, 1988, p 232–233.
R. Loevinger, T. F. Budinger and E. E. Watson, MIRD Primer for Absorbed Dose Calculations, The Society of Nuclear Medicine, 136 Madison Avenue, New York, NY.
W. S. Snyder, M. R. Ford, G. G. Wagner, and B. S. Watson. “S”, Absorbed dose per Unit Cumulated Activity for Selected Radionuclides and Organs, MIRD Pamphlet No. 11, N.Y. Society of Nuclear Medicine, 1975.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dain, J.G., Collins, J.M. & Robinson, W.T. A Regulatory and Industrial Perspective of the Use of Carbon-14 and Tritium Isotopes in Human ADME Studies. Pharm Res 11, 925–928 (1994). https://doi.org/10.1023/A:1018958631158
Issue Date:
DOI: https://doi.org/10.1023/A:1018958631158